Changes in the management of children with Cystic Fibrosis Caroline - - PowerPoint PPT Presentation

changes in the management of children with cystic
SMART_READER_LITE
LIVE PREVIEW

Changes in the management of children with Cystic Fibrosis Caroline - - PowerPoint PPT Presentation

Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre ODonovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects the lungs and digestive


slide-1
SLIDE 1

Changes in the management of children with Cystic Fibrosis

Caroline Murphy & Deirdre O’Donovan CF Nurses

slide-2
SLIDE 2

What Is Cystic Fibrosis?

Cystic fibrosis (CF) is an inherited chronic disease that primarily affects the lungs and digestive system of about 1200 children and adults in Ireland (70,000 worldwide). In Cork, the Paediatric population is 100, the Adult population is 170. A defective gene and its protein product cause the body to produce unusually thick, sticky secretions which causes

The fluid lining in the airways to be reduced, resulting in excess sticky secretions that are prone to infection and difficult to expectorate

In the pancreas, the sticky secretions block the flow of digestive juices into the gut leading to impaired digestion and poor absorption of food

slide-3
SLIDE 3
slide-4
SLIDE 4
  • very salty-tasting skin
  • productive cough
  • frequent chest infections
  • wheezing or shortness of breath
  • poor growth/weight gain in spite of a good appetite
  • frequent greasy, bulky stools or difficulty in passing stools

Symptoms of Cystic Fibrosis

slide-5
SLIDE 5
slide-6
SLIDE 6

Diagnosis

 Newborn screening  Sweat test  Genotyping  Faecal elastase

slide-7
SLIDE 7

Genetics

slide-8
SLIDE 8

Newborn Screening

 Aim of NBS is early diagnosis before presentation with respiratory

symptoms and malabsorption.

 Introduced in July 2011  Heel Prick test  6 designated CF centres  First phone call contact by CF Nurse to parents

slide-9
SLIDE 9

Newborn Screening - Cork data

2 4 6 8 10 12 14 16 18 July 11- 12 July 12 - 13 July 13-14 July 14-15 July 15- 16 July 16-17 diagnosis Calls

slide-10
SLIDE 10

Statistics

 About 50 new cases of Cystic Fibrosis in Ireland are diagnosed each year.  Because of new born screening, most babies with CF should now be diagnosed

quickly

 Around 55% of the CF patient population in Ireland is aged 18 or older.  Today, advances in research and medical treatments have further enhanced and

extended life for children and adults with CF. Many people with the disease in Ireland can now expect to live into their 30s, 40s and beyond.

slide-11
SLIDE 11

What are the changes in management

  • f children with Cystic Fibrosis?
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14

Nutrition

 Aim to maintain an appropriate weight above the 50TH centile  Appropriate weight tends to correlates with good pulmonary function  95% of CF patients are pancreatic insufficient  Creon is the pancreatic enzyme given to aid absorption of fats.  Stools should be monitored by parents, if stools are oily this means creon

needs to be adjusted by the dietician

 Fat soluble vitamins A,D,E,K are supplemented. Levels are checked

annually

 Calcium supplements maybe required to prevent osteoporosis- bone

density scan every 5yrs.

 High fat diet maybe required depending on BMI.  Nutritional supplements e.g Calogen, Fortisip, Shakes  Enteral feeds (PEG) if low BMI and FTT

slide-15
SLIDE 15

Nutrition

 Appetite stimulants  H2 antagonists and proton pump inhibitors  CF patients are at risk of Distal Intestinal Obstruction Syndrome

(DIOS) and constipation.

 CF Patients may develop Cystic Fibrosis Related Diabetes (CFRD)  Increased salt intake in hot weather and avoid dehydration

slide-16
SLIDE 16

Physiotherapy

 Past

  • child was placed prone for

precussion

 Present

  • PEP, Acapella &

Autogenic drainage

  • Increased emphasis on

physical exercise

slide-17
SLIDE 17

Pulmonary management

Excessive mucus secretion

  • bstruction

Mucus stagnation infection

Inflammation

Lung damage

 PO/IV antibiotics  Nebulised mucolytics  Nebulised antibiotics  +/- steroids  +/- antifungals  Genetic modifiers

slide-18
SLIDE 18

Infection Control l

Microbiology is fundamental to CF management

Most commonly cultured organisms:

Staph aureus

Haemophilus influenzae

Pseudomonas Aeruginosa – chronic conolisation

Aspergillus

Non tubercular mycobacteria

Antimicrobials are decided by what is cultured on throat swab or sputum if a child is symptomatic

Preventing bacterial acquisition & minimising cross infection

 Single en-suite room  No sharing of toilets as inpatient or

at clinic

 Avoid interaction with other CF

patients

 Bring own medical devices  Hospital Segregation policies  High standard of hand hygiene

must be practiced by healthcare professionals

slide-19
SLIDE 19